BRD2 and cancer: As increased ECM-remodeling may contribute to cancer cell invasion while inflammatory cytokines may promote tumor growth and metastasis27,28, this provides a potential explanation for the poorer prognosis observed among breast cancer patients with Cluster 1-enriched NAT.